Global companion diagnostic market
DUBLIN, May 1, 2024 (Globe Newswire) — The Companion Diagnostics: Technologies and Markets 2023-2028 report has been added. ResearchAndMarkets.com Recruitment.
The global companion diagnostics market is estimated to reach $15.4 billion by 2028 from $7.6 billion in 2023, at a compound annual growth rate (CAGR) of 15.2% from 2023 to 2028.
The latest report details the Companion Diagnostics market. The report focuses on the current and future market potential of Companion Diagnostics and includes an in-depth analysis of market drivers, opportunities, restraints, and challenges. This report details the companion diagnostics market share based on products and services, test type, technology, and application.
The products and services in the market are categorized into equipment, consumables, and services. It is divided into commercial CDx and laboratory developed testing (LDT)-CDx based on the type of test. Based on technology, the market is segmented into polymerase chain reaction, immunohistochemistry, next generation sequencing, in situ hybridization, genotyping, immunoassay, exosomes, others, and services market. Based on application, the CDx market is segmented into cancer, neurological diseases, cardiovascular diseases, infectious diseases, etc.
Based on end users, the companion diagnostics market is segmented into clinical laboratories, pharmaceutical companies, contract research organizations (CROs), and other end users. The report also includes a company profile of key players in the companion diagnostics market with details about each company’s business segments, financials, product portfolio, and recent developments.
Report contents
-
54 data tables and 59 additional tables
-
Global Companion Diagnostics (CDx) market overview and analysis.
-
Analyzing global market trends, including historical market revenue data (sales) from 2021 to 2022, forecasts for 2023, forecasts for 2024, and compound annual growth rate (CAGR) forecasts until 2028. To do.
-
The current and future market potential for companion diagnostics is considered along with market dynamics, competitive environment, and regulatory scenario.
-
Estimation of market size and revenue forecasts for the global CDx market and corresponding market share analysis based on products and services, testing types, technology, applications, end users, and regions.
-
We discuss the market opportunity for CDx products by focusing on the largest and fastest growing disease markets and identifying high-growth applications in various therapeutic areas.
-
Recent market developments and clinical trials, as well as analysis of leading companies engaged in CDx Reagents R&D and product development.
-
A discussion of the importance of ESG in the CDx industry, including consumer attitudes, the impact of ESG on company performance, ESG score analysis, and ESG practices followed by leading companies.
-
Review of major patent grants and patent applications related to CDx.
-
Identification of key vendors and analysis of competitive information such as company market share, recent M&A activity, and prospects for venture funding.
-
Company profiles of major industry players such as F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., and QIAGEN.
Company Profile
-
abbot
-
Agilent Technologies Co., Ltd.
-
Arup Research Institute
-
biomerieux
-
danaher company
-
F. Hoffman La Roche Co., Ltd.
-
Illumina Co., Ltd.
-
Myriad Genetics Co., Ltd.
-
Qiagen
-
Thermo Fisher Scientific Co., Ltd.
Key attributes:
|
report attributes |
detail |
|
number of pages |
121 |
|
Forecast period |
2023-2028 |
|
Estimated market value in 2023 (USD) |
7.6 billion dollars |
|
Projected market value to 2028 (USD) |
$15.4 billion |
|
compound annual growth rate |
15.2% |
|
Target area |
global |
Main topics covered:
Chapter 1 Overview
Chapter 2 Market Overview
Chapter 3 Market Trends
-
Market trend
-
market drivers
-
market constraints
-
market opportunity
-
market challenges
Chapter 4 Emerging Technologies and Development
Chapter 5 Market Segmentation Analysis
-
Segment breakdown
-
Global Companion Diagnostics Market by Products and Services
-
Market share and forecast
-
musical instrument
-
consumables
-
service
-
Global market for companion diagnostics by test type
-
Market share and forecast
-
LDT-CDx
-
Commercial CDx
-
Global market for companion diagnostics by technology
-
Market share and forecast
-
polymerase chain reaction
-
immunohistochemistry
-
next generation sequencing
-
In situ hybridization
-
genotyping
-
immunological test
-
exosome
-
others
-
service
-
Global market for companion diagnostics by application
-
Market share and forecast
-
cancer
-
CDx application market in cancer by type
-
neurological disease
-
cardiovascular disease
-
Infection
-
Other diseases
-
Market breakdown by end user
-
Market share and forecast
-
clinical laboratory
-
Pharmaceutical company
-
Contract research organization (CRO)
-
Other end users
-
Geographical breakdown
-
Global market for companion diagnostics by region
Chapter 6 Competitive Intelligence
-
market share analysis
-
Key Market Players in Companion Diagnostics Market (by Technology)
-
Grants and funding in companion diagnostics
-
Recent developments of major market players
-
clinical trial analysis
-
Clinical trial analysis by study type
-
Clinical trial analysis by status
-
Clinical trial analysis by phase
-
Clinical trial analysis by region
-
patent analysis
-
Patents by year
-
Patents, by top applicants
-
Patent by top owner
-
Patents by jurisdiction
Chapter 7 Sustainability in Companion Diagnostics: An ESG Perspective
Chapter 8 Appendix
For more information on this report, please visit https://www.researchandmarkets.com/r/xj1oko.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.
attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
